MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • MDS Virtual Congress 2021

    Subclinical inflammation and Parkinson’s disease

    G. Pagano (Basel, Switzerland)

    Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…
  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • MDS Virtual Congress 2021

    Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease

    H. Jackson, J. Anzures-Cabrera, T. Simuni, R. Postuma, G. Pagano (Welwyn Garden City, United Kingdom)

    Objective: To define a subset of Parkinson’s disease (PD) symptoms that are present in both individuals with early PD and prodromal PD, compared with age-matched…
  • MDS Virtual Congress 2021

    The fear of progression of Parkinson’s Disease

    S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)

    Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…
  • MDS Virtual Congress 2021

    The effect of Tuina in Traditional Chinese Medicine in treatment of Parkinson’s disease (Non-motor symptoms): a pilot clinical study

    FY. Chung, HY. Lai, CS. Yuen, HW. Lam, KY. Lai, SM. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)

    Objective: To evaluate the efficacy and safety of Tuina treatment in treating non-motor symptoms (NMS) of Parkinson’s disease (PD) and provide preliminary data for conducting…
  • MDS Virtual Congress 2021

    Night Vision Blindness Should Be Discussed with our Parkinson’s Disease Patients – sooner rather than later.

    L. Jaffe (Honolulu, USA)

    Objective: Visual disturbances are a common non-motor symptom of Parkinson's Disease (PD) though this is not often intuitive to many providers caring for PD patients. …
  • MDS Virtual Congress 2021

    Validation of the UCLA Loneliness Scale in Parkinson’s Disease During a Period of Social Distancing

    I. Subramanian, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: To examine the association between UCLA loneliness questionnaire (ULQ) scores and motor and non-motor symptoms (NMS) and Quality of Life (QoL) in Parkinson Disease…
  • MDS Virtual Congress 2021

    Efficacy of a 6-week brisk walking program in improving non-motor symptoms in people with Parkinson disease – a randomized controlled trial

    M. Mak, ISK. Wong-Yu, LJ. Ren (Hong Kong Sar, China)

    Objective: To examine whether the brisk walking program would be effective in alleviating non-motor symptoms, and improving sleep quality and health-related quality-of-life (HRQoL) in people…
  • MDS Virtual Congress 2021

    Nonmotor effects of subthalamic stimulation in Parkinson’s disease motor subtypes

    S. Jost, A. Konitsioti, P. Loehrer, K. Ashkan, A. Rizos, A. Sauerbier, M. Ghilardi, F. Rosenkranz, L. Strobel, A. Gronostay, M. Barbe, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Ray Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)

    Objective: To compare bilateral subthalamic stimulation (STN-DBS) effects on quality of life (QoL), motor, and nonmotor symptoms (NMS) in ‘tremor-dominant’ and ‘postural instability and gait…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 55
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley